Advertisement

Spinal Stereotactic Body Radiotherapy

  • Annie Carbonneau
  • Arjun Sahgal
  • G. Laura Masucci
Chapter

Abstract

Patients treated for advanced cancer are often diagnosed with spinal metastases. During the course of their illness, most will be offered radiation treatment with external beam radiotherapy (EBRT). With improvement in systemic therapies and increasing cancer survivorship, local control and long-term pain control become significant therapeutic goals to achieve for patients. Spine stereotactic body radiotherapy (SBRT) allows for the administration of a high-dose radiation treatment to these patients while sparing the surrounding organs at risk (OAR), namely, the spinal cord. When compared to conventional radiotherapy, SBRT for spinal metastasis seems to be associated with better local and pain control.

Keywords

Stereotactic body radiotherapy Radiation myelopathy Gross tumor volume Clinical tumor volume Planning tumor volume Metastatic epidural spinal cord compression 

References

  1. 1.
    Wong DA, Fornasier VL, MacNab I. Spinal metastases: the obvious, the occult, and the impostors. Spine (Phila Pa 1976). 1990;15(1):1–4.CrossRefGoogle Scholar
  2. 2.
    Chow E, Harris K, Fan G, et al. Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol. 2007;25(11):1423–36.PubMedCrossRefGoogle Scholar
  3. 3.
    Nguyen J, Chow E, Zeng L, et al. Palliative response and functional interference outcomes using the Brief Pain Inventory for spinal bony metastases treated with conventional radiotherapy. Clin Oncol (R Coll Radiol). 2011;23(7):485–91.CrossRefGoogle Scholar
  4. 4.
    van der Linden YM, Lok JJ, Steenland E, et al. Single fraction radiotherapy is efficacious: a further analysis of the Dutch Bone Metastasis Study controlling for the influence of retreatment. Int J Radiat Oncol Biol Phys. 2004;59(2):528–37.PubMedCrossRefGoogle Scholar
  5. 5.
    Sahgal A, Roberge D, Schellenberg D, et al. The Canadian Association of Radiation Oncology scope of practice for lung, liver and spine stereotactic body radiotherapy. Clin Oncol (R Coll Radiol). 2012;24(9):629–39.CrossRefGoogle Scholar
  6. 6.
    Sahgal A, Bilsky M, Chang EL, et al. Stereotactic body radiotherapy for spinal metastases: current status, with a focus on its application in the postoperative patient. J Neurosurg Spine. 2011;14(2):151–66.PubMedCrossRefGoogle Scholar
  7. 7.
    Chang EL, Shiu AS, Mendel E, et al. Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine. 2007;7(2):151–60.PubMedCrossRefGoogle Scholar
  8. 8.
    Shiu AS, Chang EL, Ye JS, et al. Near simultaneous computed tomography image-guided stereotactic spinal radiotherapy: an emerging paradigm for achieving true stereotaxy. Int J Radiat Oncol Biol Phys. 2003;57(3):605–13.PubMedCrossRefGoogle Scholar
  9. 9.
    Yamada Y, Bilsky MH, Lovelock DM, et al. High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int J Radiat Oncol Biol Phys. 2008;71(2):484–90.PubMedCrossRefGoogle Scholar
  10. 10.
    Yenice KM, Lovelock DM, Hunt MA, et al. CT image-guided intensity-modulated therapy for paraspinal tumors using stereotactic immobilization. Int J Radiat Oncol Biol Phys. 2003;55(3):583–93.PubMedCrossRefGoogle Scholar
  11. 11.
    Potters L, Kavanagh B, Galvin JM, et al. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2010;76(2):326–32.PubMedCrossRefGoogle Scholar
  12. 12.
    Thibault I, Chang EL, Sheehan J, et al. Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) group. Lancet Oncol. 2015;16(16):e595–603.PubMedCrossRefGoogle Scholar
  13. 13.
    Redmond KJ, Lo SS, Fisher C, et al. Postoperative stereotactic body radiation therapy (SBRT) for spine metastases: a critical review to guide practice. Int J Radiat Oncol Biol Phys. 2016;95(5):1414–28.PubMedCrossRefGoogle Scholar
  14. 14.
    Cox BW, Spratt DE, Lovelock M, et al. International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2012;83(5):e597–605.PubMedCrossRefGoogle Scholar
  15. 15.
    Redmond KJ, Robertson S, Lo SS, et al. Consensus contouring guidelines for postoperative stereotactic body radiation therapy for metastatic solid tumor malignancies to the spine. Int J Radiat Oncol Biol Phys. 2017;97(1):64–74.PubMedCrossRefGoogle Scholar
  16. 16.
    Chan MW, Thibault I, Atenafu EG, et al. Patterns of epidural progression following postoperative spine stereotactic body radiotherapy: implications for clinical target volume delineation. J Neurosurg Spine. 2016;24(4):652–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Sangha A, Korol R, Sahgal A. Stereotactic body radiotherapy for the treatment of spine metastases: an overview of the University of Toronto, Sunnybrook Health Sciences Odette Cancer Center, technique. J Med Imaging Radiat Sci. 2013;44(3):126–33.CrossRefGoogle Scholar
  18. 18.
    Jabbari S, Gerszten PC, Ruschin M, et al. Stereotactic body radiotherapy for spinal metastasis: practice guidelines, outcomes, and risks. Cancer J. 2016;22(4):280–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Redmond KJ, Lo SS, Soltys SG, et al. Consensus guidelines for postoperative stereotactic body radiation therapy for spinal metastases: results of an international survey. J Neurosurg Spine. 2017;26(3):299–306.PubMedCrossRefGoogle Scholar
  20. 20.
    Bilsky MH, Laufer I, Fourney DR, et al. Reliability analysis of the epidural spinal cord compression scale. J Neurosurg Spine. 2010;13(3):324–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Lutz S, Berk L, Chang E, et al. Palliative radiotherapy for bone metastases : an ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys. 2011;79(4):965–76.PubMedCrossRefGoogle Scholar
  22. 22.
    Al-Omair A, Masucci L, Masson-Cote L, et al. Surgical resection of epidural disease improves local control following postoperative spine stereotactic body radiotherapy. Neuro Oncol. 2013;15(10):1413–9.PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Kumar R, Nater A, Hashmi A, et al. The era of stereotactic body radiotherapy for spinal metastases and the multidisciplinary management of complex cases. Neuro Oncol Pract. 2016;3(1):48–58.Google Scholar
  24. 24.
    Fisher CG, DiPaola CP, Ryken TC, et al. A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from Spine Oncology Study Group. Spine (Phila Pa 1976). 2010;35(22):E1221–9.CrossRefGoogle Scholar
  25. 25.
    Kirshblum SC, Burns SP, Biering-Sorensen F, et al. International standards for neurological classification of spinal cord injury. J Spinal Cord Med. 2011;34:535–46.PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Laufer I, Rubin DG, Lis E, et al. The NOMS framework: approach to the treatment of spinal metastatic tumors. Oncologist. 2013;18(6):744–51.PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Bhattacharya IS, Hoskin PJ. Stereotactic body radiotherapy for spinal and bone metastases. Clin Oncol (R Coll Radiol). 2015;27(5):298–306.CrossRefGoogle Scholar
  28. 28.
    Chao ST, Koyfman SA, Woody N, et al. Recursive partitioning analysis index is predictive for overall survival in patients undergoing spine stereotactic body radiation therapy for spinal metastases. Int J Radiat Oncol Biol Phys. 2012;82(5):1738–43.PubMedCrossRefGoogle Scholar
  29. 29.
    Tang C, Hess K, Bishop AJ, et al. Creation of a prognostic index for spine metastasis to stratify survival in patients treated with spinal stereotactic radiosurgery: secondary analysis of mature prospective trials. Int J Radiat Oncol Biol Phys. 2015;93(1):118–25.PubMedCrossRefGoogle Scholar
  30. 30.
    Salama JK, Milano MT. Radical irradiation of extracranial oligometastases. J Clin Oncol. 2014;32(26):2902–12.PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Gerszten PC, Burton SA, Quinn AE, et al. Radiosurgery for the treatment of spinal melanoma metastases. Stereotact Funct Neurosurg. 2005;83(5–6):213–21.PubMedCrossRefGoogle Scholar
  32. 32.
    Leeman JE, Bilsky M, Laufer I, et al. Stereotactic body radiotherapy for metastatic spinal sarcoma: a detailed patterns-of-failure study. J Neurosurg Spine. 2016;25(1):52–8.PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Folkert MR, Bilsky MH, Tom AK, et al. Outcomes and toxicity for hypofractionated and single-fraction image-guided stereotactic radiosurgery for sarcomas metastasizing to the spine. Int J Radiat Oncol Biol Phys. 2014;88(5):1085–91.PubMedCrossRefGoogle Scholar
  34. 34.
    Ghia AJ, Chang EL, Bishop AJ, et al. Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases for spinal metastases from renal cell carcinoma: secondary analysis of phase I/II trials. J Neurosurg Spine. 2016;24(5):829–236.PubMedCrossRefGoogle Scholar
  35. 35.
    Thibault I, Al-Omair A, Masucci GL, et al. Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture. J Neurosurg Spine. 2014;21(5):711–8.PubMedCrossRefGoogle Scholar
  36. 36.
    Nguyen QN, Shiu AS, Rhines LD, et al. Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2010;76(4):1185–92.PubMedCrossRefGoogle Scholar
  37. 37.
    Brandsma D, van den Bent MJ. Pseudoprogression and pseudoresponse in the treatment of gliomas. Curr Opin Neurol. 2009;22(6):633–8.PubMedCrossRefGoogle Scholar
  38. 38.
    Walker AJ, Ruzevick J, Malayeri AA, et al. Postradiation imaging changes in the CNS: how can we differentiate between treatment effect and disease progession? Future Oncol. 2014;10(7):1277–97.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Frechette KM, Brown LC, Aubry MC, et al. Pseudoprogression after stereotactic body radiotherapy. J Thorac Oncol. 2014;9(4):e29–30.PubMedCrossRefGoogle Scholar
  40. 40.
    Stauder MC, Rooney JW, Neben-Wittich MA, et al. Late tumor pseudoprogression followed by complete remission after lung stereotactic ablative radiotherapy. Radiat Oncol. 2013;8:167.PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    Jarraya H, Mirabel X, Taieb S, et al. Image-based response assessment of liver metastases following stereotactic body radiotherapy with respiratory tracking. Radiat Oncol. 2013;8:24.PubMedPubMedCentralCrossRefGoogle Scholar
  42. 42.
    Amini B, Beaman CB, Madewell JE, et al. Osseous pseudoprogression in the vertebral bodies treated with stereotactic radiosurgery : a secondary analysis of prospective phase I/II clinical trials. AJNR Am J Neuroradiol. 2016;37(2):387–92.PubMedCrossRefGoogle Scholar
  43. 43.
    Bahig H, Simard D, Letourneau L, et al. A study of pseudoprogression after spine stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2016;96(4):848–56.PubMedCrossRefGoogle Scholar
  44. 44.
    Degen JW, Gagnon GJ, Voyadzis JM, et al. CyberKnife stereotactic radiosurgical treatment of spinal tumors for pain control and quality of life. J Neurosurg Spine. 2005;2(5):540–9.PubMedCrossRefGoogle Scholar
  45. 45.
    Gerszten PC, Burton SA, Ozhasoglu C, et al. Radiosurgery for spinal metastases : clinical experience in 500 cases from a single institution. Spine (Phila Pa 1976). 2007;32(2):193–9.CrossRefGoogle Scholar
  46. 46.
    Gagnon GJ, Nasr NM, Liao JJ, et al. Treatment of spinal tumors using CyberKnife fractionated stereotactic radiosurgery: pain and quality-of-life assessment after treatment in 200 patients. Neurosurgery. 2009;64(2):297–306.PubMedCrossRefGoogle Scholar
  47. 47.
    Wang XS, Rhines LD, Shiu AS, et al. A prospective analysis of the clinical effects of stereotactic body radiation therapy in cancer patients with spinal metastases without spinal cord compression. Lancet Oncol. 2012;13(4):395–402.PubMedPubMedCentralCrossRefGoogle Scholar
  48. 48.
    Garg AK, Shiu AS, Yang J, et al. Phase 1/2 trial of single-session stereotactic body radiotherapy for previously unirradiated spinal metastases. Cancer. 2012;118(20):5069–77.PubMedPubMedCentralCrossRefGoogle Scholar
  49. 49.
    Guckenberger M, Mantel F, Gerszten PC, et al. Safety and efficacity of stereotactic body radiotherapy as primary treatment for vertebral metastases: a multi-institutional analysis. Radiat Oncol. 2014;9:226.PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    Sahgal A, Ames C, Chou D, et al. Stereotectic body radiotherapy is effective salvage therapy for patients with prior radiation of spinal metastases. Int J Radiat Oncol Biol Phys. 2009;74(3):723–31.PubMedCrossRefGoogle Scholar
  51. 51.
    Choi CY, Adler JR, Gibbs IC, et al. Stereotactic radiosurgery for treatment of spinal metastases recurring in close proximity to previously irradiated spinal cord. Int J Radiat Oncol Biol Phys. 2010;78(2):499–506.PubMedCrossRefGoogle Scholar
  52. 52.
    Damast S, Wright J, Bilsky M, et al. Impact of dose on local failure rates after image-guided reirradiation of recurrent paraspinal metastases. Int J Radiat Oncol Biol Phys. 2011;81(3):819–26.PubMedCrossRefGoogle Scholar
  53. 53.
    Garg AK, Wang XS, Shiu AS, et al. Prospective evaluation of spinal reirradiation by using stereotactic body radiation therapy: the University of Texas experience. Cancer. 2011;117(5):3509–16.PubMedCrossRefGoogle Scholar
  54. 54.
    Mahadevan A, Floyd S, Wong E, et al. Stereotactic body radiotherapy reirradiation for recurrent epidural spinal metastases. Int J Radiat Oncol Biol Phys. 2011;81(5):1500–5.PubMedCrossRefGoogle Scholar
  55. 55.
    Chang UK, Cho WI, Kim MS, et al. Local tumor control after retreatment of spinal metastasis using stereotactic body radiotherapy: comparison with initial treatment group. Acta Oncol. 2012;51(5):589–95.PubMedCrossRefGoogle Scholar
  56. 56.
    Gerszten PC, Germanwala A, Burton SA, et al. Combination kyphoplasty and spinal radiosurgery : a new treatment paradigm for pathologic fractures. J Neurosurg Spine. 2005;3(4):296–301.PubMedCrossRefGoogle Scholar
  57. 57.
    Moulding HD, Elder JB, Lis E, et al. Local disease control after decompressive surgery and adjuvant high-dose single-fraction radiosurgery for spine metastases. J Neurosurg Spine. 2010;13(1):87–93.PubMedCrossRefGoogle Scholar
  58. 58.
    Laufer I, Iorgulescu JB, Chapman T, et al. Local disease control for spinal metastases following “separation surgery” and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery: outcome analysis in 186 patients. J Neurosurg Spine. 2013;18(3):207–14.PubMedPubMedCentralCrossRefGoogle Scholar
  59. 59.
    Tao R, Bishop AJ, Brownlee Z, et al. Stereotactic body radiation therapy for spinal metastases in the postoperative setting: a secondary analysis of mature phase 1-2 trials. Int J Radiat Oncol Biol Phys. 2016;95(5):1405–13.PubMedCrossRefGoogle Scholar
  60. 60.
    Moussazadeh N, Lis E, Katsoulakis E, et al. Five Year outcomes of high-dose single-fraction spinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2015;93(2):361–7.PubMedCrossRefGoogle Scholar
  61. 61.
    Folkert MR, Bilsky MH, Cohen GN, et al. Local recurrence outcomes using the 32P intraoperative brachytherapy plaque in the management of malignant lesions of the spine involving the dura. Brachytherapy. 2015;14(2):202–8.PubMedCrossRefGoogle Scholar
  62. 62.
    Thibault I, Campbell M, Tsen CL, et al. Salvage stereotactic body radiotherapy (SBRT) following in-field failure of initial SBRT for spinal metastases. Int J Radiat Oncol Biol Phys. 2015;93(2):353–60.PubMedCrossRefGoogle Scholar
  63. 63.
    Klekamp J, Samii H. Surgical results for spinal metastases. Acta Neurochir. 1998;140(9):957–67.PubMedCrossRefGoogle Scholar
  64. 64.
    Mizumoto M, Harada H, Asakura H, et al. Radiotherapy for patients with metastases to the spinal column: a review of 603 patients at Shizuoka Cancer Center Hospital. Int J Radiat Oncol Biol Phys. 2011;79(1):208–13.PubMedCrossRefGoogle Scholar
  65. 65.
    Sahgal A, Larson DA, Chang EL. Stereotactic body radiosurgery for spinal metastases: a critical review. Int J Radiat Oncol Biol Phys. 2008;71(3):652–65.PubMedCrossRefGoogle Scholar
  66. 66.
    Chiang A, Zeng L, Zhang L, et al. Pain flare is a commom adverse event in steroid-naïve patients after spine stereotactic body radiation therapy: a prospective clinical trial. Int J Radiat Oncol Biol Phys. 2013;86(4):638–42.PubMedCrossRefGoogle Scholar
  67. 67.
    Pan HY, Allen PK, Wang XS, et al. Incidence and predictive factors of pain flare after spine stereotactic body radiation therapy: secondary analysis of phase 1/2 trials. Int J Radiat Oncol Biol Phys. 2014;90(4):870–6.PubMedCrossRefGoogle Scholar
  68. 68.
    Chow E, Meyer RM, Ding K, et al. Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial. Lancet Oncol. 2015;16(15):1463–72.PubMedCrossRefGoogle Scholar
  69. 69.
    Rose PS, Laufer I, Boland PJ, et al. Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases. J Clin Oncol. 2009;27(30):5075–9.PubMedPubMedCentralCrossRefGoogle Scholar
  70. 70.
    Sahgal A, Atenafu EG, Chao S, et al. Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score. J Clin Oncol. 2013;31(27):3426–31.PubMedCrossRefPubMedCentralGoogle Scholar
  71. 71.
    Benedict SH, Yenice KM, Followill D, et al. Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys. 2010;37(8):4078–101.PubMedCrossRefGoogle Scholar
  72. 72.
    Sahgal A, Weinberg V, Ma L, et al. Probabilities of radiation myelopathy specific to stereotactic body radiation therapy to guide safe practice. Int J Radiat Oncol Biol Phys. 2013;85(2):341–7.PubMedCrossRefGoogle Scholar
  73. 73.
    Katsoulakis E, Jackson A, Cox B, et al. A detailed dosimetric analysis of spinal cord tolerance in high-dose spine radiosurgery. Int J Radiat Oncol Biol Phys. 2017;99(3):598–607.PubMedCrossRefGoogle Scholar
  74. 74.
    Cox BW, Jackson A, Hunt M, et al. Esophageal toxicity from high-dose, single-fraction paraspinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2012;83(5):e6661–7.Google Scholar
  75. 75.
    Masucci GL, Eugene Y, Ma L, et al. Stereotactic body radiotherapy is an effective treatment in reirradiating spinal metastases: current status and practical considerations for safe practice. Expert Rev Anticancer Ther. 2011;11(12):1923–33.PubMedCrossRefGoogle Scholar
  76. 76.
    Sahgal A, Ma L, Weinberg V, et al. Reirradiation human spinal cord tolerance for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys. 2012;82(1):107–16.PubMedCrossRefGoogle Scholar
  77. 77.
    Sellin JN, Suki D, Harsh V, et al. Factors affecting survival in 43 consecutive patients after surgery for spinal metastases from thyroid carcinoma. J Neurosurg Spine. 2015;23(4):419–28.PubMedCrossRefGoogle Scholar
  78. 78.
    Fehlings MG, Nater A, Tetreault L, et al. Survival and clinical outcomes in surgically treated patients with metastatic epidural spinal cord compression: results of the prospective multicenter AOSpine study. J Clin Oncol. 2016;34(3):268–76.PubMedCrossRefGoogle Scholar
  79. 79.
    Harel R, Emch T, Chao S, et al. Quantitative evaluation of local control and wound healing following surgery and stereotactic spine radiosurgery (SRS) for spine tumors. World Neurosurg. 2016;87:48–54.PubMedCrossRefGoogle Scholar
  80. 80.
    Massicotte E, Foote M, Reddy R, et al. Minimal access spine surgery (MASS) for decompression and stabilization performed as an out-patient procedure for metastatic spinal tumours followed by spine stereotactic body radiotherapy (SBRT): first report of technique and preliminary outcomes. Technol Cancer Res Treat. 2012;11(1):15–25.PubMedCrossRefGoogle Scholar
  81. 81.
    Heron DE, Rajagopalan MS, Stone B, et al. Single-session and multisession CyberKnife radiosurgery for spine metastases-University of Pittsburgh and Georgetown University experience. J Neurosurg Spine. 2012;17(1):11–8.PubMedCrossRefGoogle Scholar
  82. 82.
    Redmond KJ, Sahgal A, Foote M, et al. Single versus multiple session stereotectic body radiotherapy for spinal metastasis: the risk-benefit ratio. Future Oncol. 2015;11(17):2405–15.PubMedCrossRefGoogle Scholar
  83. 83.
    Schueneman AJ, Himmelfarb E, Geng L, et al. SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models. Cancer Res. 2003;63(14):4009–16.PubMedGoogle Scholar
  84. 84.
    Staehler M, Haseke N, Nuhn P, et al. Simultaneous anti-angiogenic therapy and single-fraction radiosurgery in clinically relevant metastases from renal cell carcinoma. BJU Int. 2011;108(5):673–8.PubMedGoogle Scholar
  85. 85.
    Park S, Kim KH, Rhee WJ, et al. Treatment outcome of radiation therapy and concurrent targeted molecular therapy in spinal metastasis from renal cell carcinoma. Radiat Oncol J. 2016;34(2):128–34.PubMedPubMedCentralCrossRefGoogle Scholar
  86. 86.
    Miller JA, Balagamwala EH, Angelov L, et al. Spine stereotactic radiosurgery with concurrent tyrosine kinase inhibitors for metastatic renal cell carcinoma. J Neurosurg Spine. 2016;25(6):766–74.PubMedCrossRefGoogle Scholar
  87. 87.
    Peters NA, Richel DJ, Verhoeff JJ, et al. Bowel perforation after radiotherapy in a patient receiving sorafenib. J Clin Oncol. 2008;26(14):2405–6.PubMedCrossRefGoogle Scholar
  88. 88.
    Basille D, Andrejak M, Bentayeb H, et al. Bronchial fistula associated with sunitinib in a patient previously treated with radiation therapy. Ann Pharmacother. 2010;44(2):383–6.PubMedCrossRefGoogle Scholar
  89. 89.
    Kim H, Rajagopalan MS, Beriwal S, et al. Cost-effectiveness analysis of single fraction of stereotactic body radiation therapy compared with single fraction of external beam radiation therapy for palliation of vertebral bone metastases. Int J Radiat Oncol Biol Phys. 2015;91(3):556–63.PubMedCrossRefGoogle Scholar
  90. 90.
    Bijlani A, Aguzzi G, Schaal DW, et al. Stereotactic radiosurgery and stereotactic body radiation therapy cost-effectiveness results. Front Oncol. 2013;3:77.PubMedPubMedCentralCrossRefGoogle Scholar
  91. 91.
    Hyde D, Lochray F, Korol R, et al. Spine stereotactic body radiotherapy utilizing cone-beam CT image-guidance with a robotic cough: intrafraction motion analysis accounting for all six degrees of freedom. Int J Radiat Oncol Biol Phys. 2012;82(3):e555–62.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Annie Carbonneau
    • 1
  • Arjun Sahgal
    • 2
  • G. Laura Masucci
    • 3
  1. 1.Department of Radiation OncologyJewish General Hospital of MontrealMontrealCanada
  2. 2.Department of Radiation OncologySunnybrook Odette Cancer CentreTorontoCanada
  3. 3.Department of Radiation OncologyCentre Hospitalier de l’Universite de Montreal (CHUM)MontrealCanada

Personalised recommendations